Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA
1 other identifier
interventional
140
1 country
1
Brief Summary
This study will combine brain imaging and neuromodulation tools to investigate the underlying neurobiological mechanisms of exercises. The findings will enhance our understanding of the mechanisms underlying mind-body exercise and facilitate the development of new pain management approaches.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2 knee-osteoarthritis
Started Mar 2024
Longer than P75 for phase_2 knee-osteoarthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 19, 2023
CompletedFirst Posted
Study publicly available on registry
May 3, 2023
CompletedStudy Start
First participant enrolled
March 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2028
May 7, 2025
May 1, 2025
4.1 years
April 19, 2023
May 6, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
M1 resting state functional connectivity
Changes in brain resting-state connectivity between the primary motor cortex (M1) and other brain regions pre- and post-treatments, analyzed using the CONN Toolbox (https://web.conn-toolbox.org/)
Baseline, post-treatment (12 weeks)
Secondary Outcomes (9)
Change on Cerebral blood flow
Baseline, post-treatment (12 weeks)
Change on M1 corticospinal excitability and cortico-cortical excitability
Baseline, post-treatment (12 weeks)
Change on brain gray matter volume
Baseline, post-treatment (12 weeks)
Change on Knee Injury and Osteoarthritis Outcome Score (KOOS)
Baseline, post-treatment (12 weeks), follow-up (24 weeks)
Change on Patient-Reported Outcomes Measurement Information System (PROMIS)-29
Baseline, post-treatment (12 weeks), follow-up (24 weeks)
- +4 more secondary outcomes
Study Arms (4)
BDJ + real tDCS
ACTIVE COMPARATORExercise + real tDCS
ACTIVE COMPARATORBDJ + sham tDCS
ACTIVE COMPARATORExercise + sham tDCS
ACTIVE COMPARATORInterventions
exercise including stretching and other activities.
Eligibility Criteria
You may qualify if:
- Volunteers 45-75 years of age
- Meet the Classification Criteria of the American College of Rheumatology for osteoarthritis of the right and/or left knee for at least the past 3 months;
- Physically able to participate in the BDJ and stretching control education programs
- Willing to complete the 12-week study
- Can participate in MRI scan
- Ability to read and understand English; English can be a second language provided that the patient feels he or she can understand all the questions used in the assessment measures
You may not qualify if:
- Has performed BDJ, Tai Chi, Yoga, other mind-body intervention, physical therapy, or routine exercise (running, cycling, etc.) regularly in the past year
- Serious medical conditions limiting ability of patient to participate in the study, such as symptomatic cardiovascular disease, symptomatic pulmonary disease requiring supplemental oxygen, uncontrolled metabolic diseases, severe renal and liver disease
- Has had intra-articular steroid injections or reconstructive surgery in the prior 3 months on the affected knee; any intra-articular hyaluronic acid injections in the previous 6 months
- Patient Mini-Mental Status Examination score below 24 \[293\]
- Unable to walk without a cane or other assistive device
- The intent to undergo surgery during the time of involvement in the study
- Plan to permanently relocate from the region during the trial period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Charlestown, Massachusetts, 02129, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
April 19, 2023
First Posted
May 3, 2023
Study Start
March 5, 2024
Primary Completion (Estimated)
March 30, 2028
Study Completion (Estimated)
August 31, 2028
Last Updated
May 7, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share